Showing results (2311-2320 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|July 5, 2011
Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trialEvgeny Rakhman, Dmitri Shmain, Ian White, et al.
Clinical Therapeutics|July 5, 2011
Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjectsM Cristina Castelli, Diane F Wong, Kristen Friedman, et al.
Clinical Therapeutics|July 12, 2011
Review of the therapeutic uses of liraglutideGina J Ryan, Karla T Foster, Lynetta Johnson Jobe
Clinical Therapeutics|March 24, 2007
The history and contemporary challenges of the US Food and Drug AdministrationAndrea T Borchers, Frank Hagie, Carl L Keen, et al.
Clinical Therapeutics|March 24, 2007
Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disordersDaniel M Tassone, Eric Boyce, Jennifer Guyer, et al.
Clinical Therapeutics|March 24, 2007
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adultsJames L Pool, Robert Glazer, Myron Weinberger, et al.
Clinical Therapeutics|March 24, 2007
Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavageJunko Kikuchi, Koichi Yamazaki, Eiki Kikuchi, et al.
Clinical Therapeutics|March 24, 2007
A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adultsKyungsoo Park, Yu Seun Kim, Kwang-Il Kwon, et al.
Clinical Therapeutics|September 11, 1991
The use of human insulin derived from baker's yeast by recombinant DNA technologyP Raskin, R S Clements
Clinical Therapeutics|September 1, 1991
Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study GroupR J Brown, D H Batts, G S Hughes, et al.
Pageof 680